Q4 2023 13F Holders as of 31 Dec 2023
-
Type / Class
-
Equity / COM NEW
-
Number of holders
-
42
-
Total 13F shares, excl. options
-
4,683,824
-
Shares change
-
+1,520,307
-
Total reported value, excl. options
-
$14,095,638
-
Value change
-
+$8,406,813
-
Put/Call ratio
-
55%
-
Number of buys
-
39
-
Number of sells
-
-2
-
Price
-
$3.01
Significant Holders of Fortress Biotech, Inc. - COM NEW (FBIO) as of Q4 2023
47 filings reported holding FBIO - Fortress Biotech, Inc. - COM NEW as of Q4 2023.
Fortress Biotech, Inc. - COM NEW (FBIO) has 42 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 4,683,824 shares
.
Largest 10 shareholders include CVI Holdings, LLC (764,549 shares), Rosalind Advisors, Inc. (607,797 shares), ARMISTICE CAPITAL, LLC (596,000 shares), Altium Capital Management LP (405,122 shares), Nantahala Capital Management, LLC (372,562 shares), VANGUARD GROUP INC (353,893 shares), Hudson Bay Capital Management LP (327,235 shares), SHIKIAR ASSET MANAGEMENT INC (183,136 shares), PVG ASSET MANAGEMENT CORP (131,490 shares), and ACADIAN ASSET MANAGEMENT LLC (130,188 shares).
This table shows the top 42 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.